Skip to main content
IOFINA PLC logo

IOFINA PLC — Investor Relations & Filings

Ticker · IOF ISIN · GB00B2QL5C79 LEI · 213800QDMFYVRJYYTQ84 IL Manufacturing
Open in API
Filings indexed 400 across all filing types
Latest filing 2013-01-14 Board/Management Inform…
Country GB United Kingdom
Listing IL IOF

About IOFINA PLC

https://iofina.com

Iofina PLC is a vertically integrated company specializing in the exploration and production of iodine and the manufacturing of specialty chemical derivatives. The company utilizes its proprietary WET® IOsorb® technology to extract iodine from brine water streams, a co-product of oil and gas operations. This sustainable process isolates a valuable resource from what would otherwise be a waste stream. The extracted crystalline iodine is sold globally and also used internally by its Iofina Chemical division. Iofina Chemical manufactures a diverse portfolio of iodine-based derivatives and other non-iodine specialty chemicals. These products serve a wide range of global markets, including the pharmaceutical, animal care, nutrition, agrochemical, and biocide sectors.

Recent filings

Filing Released Lang Actions
Appointment of Non-Executive Director
Board/Management Information Classification · 99% confidence The document is a formal announcement dated January 14, 2013, disseminated via RNS (Regulatory News Service), which is a common channel for LSE-listed companies. The core content announces the 'Appointment of Non-Executive Director' and provides biographical details, current directorships, and shareholding information for the new director, Mr. Stuart Michael Eaton. This directly matches the definition for 'Board/Management Information' (MANG), which covers announcements of changes in the company's board of directors or senior management. It is not a full report (10-K, IR), a financial result (ER, IR), or a general regulatory filing fallback (RNS), as it pertains to a specific management change.
2013-01-14 English
Commissioning of IO#2 IOsorbT Plant
Regulatory Filings Classification · 99% confidence The document begins with an 'RNS Number' and a date, indicating it is a regulatory announcement disseminated via the London Stock Exchange's Regulatory News Service (RNS). The content announces the 'Commissioning of IO#2 IOsorb™ Plant,' which is an operational update regarding the company's assets and business progress. This type of operational news, which is not a formal financial report (like 10-K or IR), dividend notice, or management change, typically falls under general regulatory announcements. Since 'Regulatory Filings' (RNS) is defined as the fallback for miscellaneous filings that do not fit elsewhere, and this is clearly an RNS dissemination, this is the most appropriate classification. The document length is relatively short (3866 chars), but it is providing substantive news, not just announcing another report, so RPA is less likely than RNS.
2013-01-11 English
Group of companies' accounts made up to 2011-12-31
Regulatory Filings
2012-07-03 English
Group of companies' accounts made up to 2010-12-31
Regulatory Filings
2011-07-05 English
Group of companies' accounts made up to 2009-12-31
Regulatory Filings
2010-10-11 English
Group of companies' accounts made up to 2008-12-31
Regulatory Filings
2009-09-03 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.